isothiocyanic acid has been researched along with Carcinoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, H; Jin, L; Lin, S; Zhang, Y | 1 |
Bakare, A; Bertele, D; Drognitz, O; Erlacher, M; Giesemann, T; Hertrampf, A; Herz, C; Huber, R; Lamy, E; Lauer, U; Mersch-Sundermann, V; Rohn, S; Schüler, J; Wagner, M; Weiland, T | 1 |
1 review(s) available for isothiocyanic acid and Carcinoma, Hepatocellular
Article | Year |
---|---|
Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Isothiocyanates; Liver Neoplasms | 2022 |
1 other study(ies) available for isothiocyanic acid and Carcinoma, Hepatocellular
Article | Year |
---|---|
Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Immunoblotting; Isothiocyanates; Liver Neoplasms; Mice; Mice, Nude; Mutation; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |